MAMasarrat Afroz

Masarrat Afroz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Masarrat Afroz has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prenatal imaging for hypospadias: a bayesian analysis-based systematic review of diagnostic accuracy and key imaging features

    by Shivani Phugat, Komal Kaur Saroya, Prativa Choudhury, Vivek Verma, Vikas Dhikav, Masarrat Afroz, Vishesh Jain, Anjan Kumar Dhua, Devendra Kumar Yadav, Prabudh Goel

    Background The antenatal diagnosis of hypospadias has implications for parental counselling, decision-making and organizing postnatal management. Recent imaging advancements have enabled antenatal detection of hypospadias with significant implications for parental psychology and clinical management. However, there is considerable variability in the application of the diagnostic techniques and their reliability or diagnostic accuracy. Objective To assess the diagnostic accuracy of prenatal imaging modalities in the antenatal detection of hypospadias using a Bayesian statistical framework and to identify key imaging features that enhance prenatal diagnosis. Materials and methods Comprehensive searches across PubMed, Scopus and Google Scholar identified primary research on antenatal hypospadias diagnosis, which was subject to systematic review as per PRISMA guidelines. A Bayesian model employing non-informative priors (Beta (1,1)) was used to calculate pooled sensitivity and specificity, along with corresponding 95% credible intervals, enabling the probabilistic quantification of diagnostic uncertainty. Results The review included 34 studies published between 1989 and 2023, representing 280 pregnant females with 282 foetuses. Bayesian analysis revealed high sensitivity (0.87; 95% CrI: 0.80–0.92) and moderate specificity (0.46; 95% CrI: 0.34–0.58), translating into reliable detection of cases, though with a higher risk of false positives. While 2D sonography served as the universal screening tool (100%), supplementary techniques included 3D sonography (32.3%), color Doppler (32.3%) and magnetic resonance imaging (8.8%). Diagnosis occurred at a mean gestational age of 26.3 ± 5.5 weeks (range 20–39 weeks). Key imaging features identified were ventral curvature (n = 62), a shortened penile shaft (n = 52), a blunt penile tip (n = 60), Meizner’s tulip sign (n = 51) and a bifid scrotum (n = 20). The tulip sign, bifid scrotum and cranially-directed phallus were exclusively associated with proximal variants. Conclusions While 2D-ultrasonography remains the primary investigative modality, antenatal detection of hypospadias may be improved through the integration of 3D ultrasound, Doppler and MRI, particularly in complex cases. Confirmatory postnatal evaluation is crucial to address the moderate specificity and risk of false-positive results. However, there is a need to address the disparities in access to advanced imaging and technical expertise in prenatal diagnosis.


  • Serum matrix metalloproteinase-7 (MMP-7) as a Biomarker for differentiating biliary atresia from neonatal hepatitis: evidence synthesis through systematic review and meta-analysis

    by Prativa Choudhury, Anjan Kumar Dhua, Vishesh Jain, Devendra Kumar Yadav, Teg Rabab Singh, Masarrat Afroz, Vikas Dhikav, Sandeep Agarwala, Prabudh Goel

    Purpose Biliary atresia (BA) requires timely differentiation from neonatal hepatitis (NH) and early surgery for optimal outcomes. This systematic review and meta-analysis evaluated the diagnostic performance of serum Matrix metalloproteinase-7 (MMP-7) as a biomarker for differentiating BA from NH. Methods The PRISMA-DTA compliant synthesis was based upon primary data available till date, assessing the role of MMP-7 in diagnosing BA. Studies reporting diagnostic accuracy metrics were included. Pooled sensitivity, specificity, likelihood ratios, diagnostic odds ratio (DOR) and area under the summary receiver operating characteristic (SROC) curve were calculated. Results Twenty-four studies (7298 participants: 3301 BA, 2,930 NH and 1067 controls) were analysed. The serum MMP-7 values ranged from 1.2 to 10.3 ng/mL in controls, 1.88–12.57 ng/mL in NH and 10.26–121.1 ng/mL in BA, with interquartile ranges spanning 1.08–25.3, 0.78–34.0 and 3.38–368.0 ng/mL, respectively. Median serum MMP-7 levels were consistently higher in BA vis-a-vis NH and the control population. Pooled sensitivity and specificity of MMP-7 as a diagnostic biomarker were 0.94 and 0.88, respectively. The DOR was 120.09 and the SROC AUC was 0.967. Conclusion Serum MMP-7 demonstrates excellent diagnostic accuracy for differentiating BA from NH. Further research should focus on assay standardization and age-specific reference ranges to optimize clinical utility.